The United Kingdom on Wednesday indefinitely banned new prescriptions of puberty blockers to treat minors for gender dysphoria. The announcement comes a week after the U.S. Supreme Court heard oral arguments in a case involving state bans on puberty-suppressing medication and other forms of transition-related care for minors.

Puberty blockers are commonly prescribed to transgender children in countries throughout the Western world to delay the onset of puberty or pause it as it is…